Cosmos Health Inc. 8-K

What Happened Cosmos Health Inc. (NASDAQ: COSM) filed a Current Report on Form 8-K reporting a material modification to the rights of security holders: the company filed a Certificate of Designation establishing Series B Preferred Stock (Exhibit 3.1) dated July 16, 2026. The filing also reports the results of the company’s 2026 Annual Meeting of Stockholders held on July 15, 2026, at which six directors were elected to serve until the next annual meeting and until their successors qualify.

Key Details

• Annual Meeting date: July 15, 2026.
• Directors elected: Grigorios Siokas; Demetrios G. Demetriades; John J. Hoidas; Dr. Anastasios Aslidis; Suhel Bhutawala; Theodoros C. Karkantzos.
• Certificate of Designation: Series B Preferred Stock document filed as Exhibit 3.1, dated July 16, 2026 (reported under Item 3.03).
• Filing references: Items 3.03 (material modification to rights), 5.07 (submission of matters to a vote), and 9.01 (exhibits).

Why It Matters The filing signals a formal change to the company’s capital structure through the creation/designation of Series B preferred shares, which can affect shareholder rights, priorities and potential future financing or dividend arrangements. The newly elected board members will serve through the next annual meeting. Investors should review the Certificate of Designation (Exhibit 3.1) and the full 8-K to understand the specific rights, preferences or restrictions attached to the Series B shares and assess any potential impact on common shareholders.